Get to know our divisions and growth strategy.
Pharmadrug owns 100% of Sairiyo Therapeutics, a biotech company that specializes in repurposing and reformulating established natural medicines and psychedelics with a goal of bringing them efficiently through the regulatory approval process in multiple jurisdictions. The Company has secured exclusive rights to a novel, enteric-coated and highly bioavailable oral formulation of cepharanthine, a drug that has been in used safely and effectively in Japan for over 70 years to treat multiple forms of cancer and viral disease. The Company also has an active psychedelics R&D program that focuses primarily on novel uses and formulations of DMT (N,N-Dimethyltryptamine).